News

White House Coronavirus Testing Czar Brett Giroir Says Nation Should ‘Move On’ From Hydroxychloroquine

The White House coronavirus task force leader charged with coronavirus testing said on Sunday the country needs to “move on” from the Trump-championed drug hydroxychloroquine citing no evidence in using it in coronavirus treatment.

In an interview with NBC’s Meet The Press, Adm. Brett Giroir, assistant secretary of health and human services, confirmed that the anti-malaria drug hydroxychloroquine was deemed ineffective in coronavirus treatment by “five randomized control, placebo-controlled trials.”

“From a public health standpoint, at first, hydroxychloroquine looked very promising. There were not the definitive studies. At this point in time, there’s been five randomized control, placebo-controlled trials that do not show any benefit to hydroxychloroquine. So at this point in time, we don’t recommend that as a treatment,” he said.

“So, at this point in time, we don’t recommend that as a treatment. There’s no evidence to show that it is,” Giroir added.

Subscribe to our free weekly newsletter!

A week of political news in your in-box.
We find the news you need to know, so you don't have to.

His comment supports Dr. Antony Fauci‘s arguments on the anti-malaria drug. Last week, in an interview with MSNBC, Fauci said that “the scientific data and the evidence… show consistently that Hydroxychloroquine is not effective in the treatment of coronavirus disease or COVID-19.”

President Donald Trump, meanwhile, has continuously touted the drug since the early stages of the pandemic. In March, he called the drug “a game-changer” and in May he claimed he took hydroxychloroquine as a preventive measure. Despite concerns from health officials, Trump said it worked with “no problems.”

“I happen to believe in it. I would take it. As you know, I took it for a 14-day period. And as you know, I’m here. I happen to think it works in the early stages,” Trump said.

Last month, FDA has revoked hydroxychloroquine’s authorization for emergency use, deeming it ineffective, as well as citing heart arrhythmia as a side effect.

Polina Kuznetsova

Share
Published by
Polina Kuznetsova

Recent Posts

Judge Rules Trump’s Efforts To Cancel Hundreds Of DEI-Base Research Grants Are Illegal: ‘Have We No Shame?’

A federal judge ruled that President Donald Trump's attempts to cancel several hundred National Institutes…

17 hours ago

Paramount Settles With Trump For $16M Over Accusations Of ‘Distortion’ Favoring Kamala Harris, Critics Call It ‘Extortion’

Paramount and President Donald Trump agreed to a $16 million settlement regarding how an interview…

17 hours ago

Trump Threatens To Add New Tariffs To Countries That Haven’t Reached Trade Deals With U.S.

Treasury Secretary Scott Bessent announced that tariffs will return to the "Independence Day" levels if,…

17 hours ago

Netanyahu Surprises Trump With Nobel Peace Prize Nomination During White House Meeting

On Monday, Israeli Prime Minister Benjamin Netanyahu surprised President Donald Trump with a nomination for…

18 hours ago

After Musk-Trump Feud, Air Force Cancels Tests With Advanced SpaceX Rockets

The United States Air Force has announced that it will cease collaboration with SpaceX on…

20 hours ago

Treasury Secretary Scott Bessent Says Democrats Think ‘Poor People Are Stupid,’ Shouldn’t Be Worried About GOP Medicaid Cuts

President Donald Trump's "Big, Beautiful Bill" became law on July 4. The bill includes cuts…

1 day ago